Glaucoma: all 1,844 studies

Page 5 of 19. Open to participants first (233), then studies with results posted, then the rest; newest registration first within each.

• Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueCompletedNCT01937312Phase 4Results posted
• Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®CompletedNCT01937299Phase 4Results posted
• A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or GlaucomaCompletedNCT01936389Phase 2Results posted
• The Effects of an Antioxidant Formulation on Ocular Blood FlowCompletedNCT01930487Not applicableResults posted
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01915940Phase 2Results posted
• Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in GlaucomaCompletedNCT01912599Not applicableResults posted
• Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHTCompletedNCT01895972Phase 3Results posted
• Comparison of Silicone and Porous Plate Ahmed Glaucoma ValvesCompletedNCT01883856Not applicableResults posted
• InnFocus MicroShunt Versus Trabeculectomy StudyCompletedNCT01881425Not applicableResults posted
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01881126Phase 4Results posted
• A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular HypertensionCompletedNCT01863953Phase 2Results posted
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical ReasonsCompletedNCT01853085Results posted
• Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket CohortCompletedNCT01836042Results posted
• A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT01830140Phase 3Results posted
• Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression PatientsTerminatedNCT01828255Not applicableResults posted
• A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular HypertensionTerminatedNCT01781962Results posted
• Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749930Phase 3Results posted
• Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749904Phase 3Results posted
• An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering TreatmentsCompletedNCT01735214Results posted
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01731002Phase 2Results posted
• Use of Intravitreal Aflibercept Injection for Neovascular GlaucomaCompletedNCT01711879Not applicableResults posted
• Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle GlaucomaCompletedNCT01711177Not applicableResults posted
• BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01707381Phase 2Results posted
• Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma PatientsCompletedNCT01682460Phase 4Results posted
• Glaucoma BiomarkersCompletedNCT01677507Phase 4Results posted
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®CompletedNCT01664039Phase 4Results posted
• Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma PatientsCompletedNCT01658839Phase 1Results posted
• Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma PatientsCompletedNCT01652664Phase 3Results posted
• Optical Coherence Tomography (OCT) Data Collection StudyCompletedNCT01641835Results posted
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to MonotherapyCompletedNCT01637246Results posted
• A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01632423Results posted
• A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01628614Results posted
• GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to MonotherapyCompletedNCT01628601Results posted
• Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01628588Results posted
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)CompletedNCT01594970Phase 4Results posted
• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01589510Results posted
• Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01568008Results posted
• Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage ImplantCompletedNCT01563237Not applicableResults posted
• IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway PressureCompletedNCT01560975Not applicableResults posted
• Shunt Tube Exposure Prevention StudyCompletedNCT01551550Not applicableResults posted
• Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)CompletedNCT01540370Results posted
• Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)CompletedNCT01539239Not applicableResults posted
• Study of AR-13324 in Patients With Elevated Intraocular PressureCompletedNCT01528787Phase 2Results posted
• Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric GlaucomaCompletedNCT01527682Phase 2Results posted
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular HypertensionCompletedNCT01525173Phase 4Results posted
• Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin AmericaCompletedNCT01518244Phase 4Results posted
• Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in BrazilTerminatedNCT01514734Phase 4Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01510145Phase 4Results posted
• The Effects of the Water Drinking Test on Intraocular PressureCompletedNCT01507584Not applicableResults posted
• Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT01494753Phase 2Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01493427Phase 4Results posted
• Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01489670Results posted
• AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular PressureCompletedNCT01484951Phase 4Results posted
• How Has Glaucoma Affected Your Quality of Life?CompletedNCT01476644Not applicableResults posted
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)CompletedNCT01464424Phase 4Results posted
• Travoprost 3-Month Safety and Efficacy StudyCompletedNCT01453855Phase 3Results posted
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01426867Phase 2Results posted
• A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With GlaucomaTerminatedNCT01426113Phase 3Results posted
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaCompletedNCT01415401Phase 4Results posted
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01357616Phase 3Results posted
• DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01343082Phase 3Results posted
• DE-111 Against Timolol Ophthalmic Solution 0.5%CompletedNCT01342094Phase 3Results posted
• DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%CompletedNCT01342081Phase 3Results posted
• Patient Preference Comparison of AZARGA Versus COSOPTCompletedNCT01340014Phase 4Results posted
• Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololCompletedNCT01336569Phase 4Results posted
• Efficacy of Changing to DUOTRAV® From Prior TherapyCompletedNCT01327599Phase 4Results posted
• SENSIMED Triggerfish Safety and TolerabilityCompletedNCT01319617Not applicableResults posted
• Effects of Anti-Glaucoma Medications on the Ocular SurfaceTerminatedNCT01315574Phase 4Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01310777Phase 3Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01309204Phase 3Results posted
• Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood FlowCompletedNCT01308788Results posted
• Does Glaucoma Cause Loss of Brain Function?CompletedNCT01303939Not applicableResults posted
• Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01298700Phase 4Results posted
• Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%CompletedNCT01297920Phase 3Results posted
• Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01297517Phase 3Results posted
• Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01291108Phase 2Results posted
• Prospective Randomized Study Comparing Ex-PRESS to TrabeculectomyCompletedNCT01263561Not applicableResults posted
• Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyCompletedNCT01263444Phase 4Results posted
• Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)CompletedNCT01254604Phase 3Results posted
• Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01253902Phase 4Results posted
• Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been TreatedCompletedNCT01243567Phase 4Results posted
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01241240Phase 3Results posted
• Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNCT01229462Not applicableResults posted
• COSOPT-S® Treatment Versus Acetazolamide Before TrabeculectomyCompletedNCT01228149Phase 4Results posted
• Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01223378Phase 2Results posted
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01217606Phase 3Results posted
• Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular HypertensionCompletedNCT01216943Phase 3Results posted
• Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT01215786Phase 1Results posted
• Observational Study of the Long-term Effect of Latanoprost in Normal Tension GlaucomaCompletedNCT01209624Results posted
• Long Term Use Of Xalacom In Patients Glaucoma Or Ocular HypertensionCompletedNCT01191008Results posted
• Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01177098Phase 3Results posted
• Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension GlaucomaCompletedNCT01175902Not applicableResults posted
• Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®CompletedNCT01170884Phase 4Results posted
• Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical TherapyCompletedNCT01166659Not applicableResults posted
• Use of Bevacizumab in Trabeculectomy SurgeryCompletedNCT01166594Phase 4Results posted
• Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular HypertensionCompletedNCT01157364Phase 1/2Results posted
• Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous PatientsCompletedNCT01156012Phase 3Results posted
• Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.CompletedNCT01155219Phase 4Results posted
• Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma PatientsTerminatedNCT01151904Phase 4Results posted
• Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective DataCompletedNCT01145898Results posted

← Glaucoma overview